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Oxygenation Index in the First 24 Hours after the 
Diagnosis of Acute Respiratory Distress Syndrome as a 
Surrogate Metric for Risk Stratification in Children
Background: The diagnosis of pediatric acute respiratory distress syndrome (PARDS) is a 
pragmatic decision based on the degree of hypoxia at the time of onset. We aimed to 
determine whether reclassification using oxygenation metrics 24 hours after diagnosis could 
provide prognostic ability for outcomes in PARDS.
Methods: Two hundred and eighty-eight pediatric patients admitted between January 1, 
2010 and January 30, 2017, who met the inclusion criteria for PARDS were retrospectively 
analyzed. Reclassification based on data measured 24 hours after diagnosis was compared 
with the initial classification, and changes in pressure parameters and oxygenation were 
investigated for their prognostic value with respect to mortality.
Results: PARDS severity varied widely in the first 24 hours; 52.4% of patients showed an 
improvement, 35.4% showed no change, and 12.2% either showed progression of PARDS or 
died. Multivariate analysis revealed that mortality risk significantly increased for the severe 
group, based on classification using metrics collected 24 hours after diagnosis (adjusted odds 
ratio, 26.84; 95% confidence interval [CI], 3.43 to 209.89; P=0.002). Compared to changes in 
pressure variables (peak inspiratory pressure and driving pressure), changes in oxygenation 
(arterial partial pressure of oxygen to fraction of inspired oxygen) over the first 24 hours showed 
statistically better discriminative power for mortality (area under the receiver operating chara-
cteristic curve, 0.701; 95% CI, 0.636 to 0.766; P<0.001).
Conclusions: Implementation of reclassification based on oxygenation metrics 24 hours after 
diagnosis effectively stratified outcomes in PARDS. Progress within the first 24 hours was 
significantly associated with outcomes in PARDS, and oxygenation response was the most 
discernable surrogate metric for mortality.
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INTRODUCTION
Acute respiratory distress syndrome (ARDS) refers to a condition of acute lung injury and in-
flammation that leads to hypoxic respiratory failure. Although there is general agreement 
that ARDS can affect people of all ages [1], the original and revised definitions of ARDS (i.e., 
the American-European Consensus Conference definition in 1994 [2] and the Berlin defini-
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tion in 2012 [3]) did not include pediatric considerations. As 
the pediatric population exhibits a distinctive epidemiology 
and prognosis [4], as well as intrinsic differences in respiratory 
physiology [5], the Pediatric Acute Lung Injury Consensus 
Conference (PALICC) established new definitions for pediat-
ric ARDS (PARDS) in 2015 [6]. The key differences included in 
these PALICC criteria are the use of an oxygenation index (OI) 
for severity stratification instead of the ratio of the arterial par-
tial oxygen pressure to the fraction of inspired oxygen (PaO2/
FiO2), allowance for pulse oximetry-based metrics (e.g., oxy-
genation saturation index [OSI]) when PaO2 is not available, 
less stringent chest radiograph standards, and a broader scope 
by including subjects with chronic lung disease and cyanotic 
heart disease [6].
 The incidence of PARDS is reported as 1%–4% of pediatric 
intensive care unit (ICU) admissions [7,8]. Despite improve-
ments in the quality of intensive care, PARDS still is a major 
challenge in the pediatric ICU due to mortality as high as 30% 
[7,9]. As most treatment strategies for PARDS have been ex-
trapolated from evidence gathered in adult studies, there is a 
growing need for interventional trials focused on pediatric 
populations. Likewise, risk stratification and identification of 
high-risk cases of PARDS have been attempted to better un-
derstand patient populations and optimize the quality of care. 
 Although the above definitions use oxygenation metrics as 
a primary indicator for lung injury, there remains a lack of 
guidance regarding when clinicians should acquire the met-
rics for PARDS risk stratification. With regard to PaO2/FiO2, OI 
and OSI are influenced by ventilator settings [10-12] and vary 
according to the disease progression; thus, the timing of mea-
suring these metrics should be considered during risk stratifi-
cation. Notably, several recent reports [8,13,14] have shown 
that mortality discrimination in PARDS is improved with the 
use of oxygenation metrics within the first 24 hours after onset 
relative to using initial metrics.
 In this study, we aimed to determine whether reclassification 
using oxygenation metrics 24 hours after diagnosis of PARDS 
would have prognostic ability in an Asian cohort. Respiratory 
variables to be used as early prediction factors for risk stratifi-
cation in PARDS were also investigated.
MATERIALS AND METHODS
Patient Selection
A total of 1,101 patients aged 1 month to 19 years who were 
treated in the medical ICU of a medical ICU of Severance Hos-
pital between January 1, 2010 and January 30, 2017 were screen-
KEY MESSAGES 
■  Pediatric acute respiratory distress syndrome (PARDS) 
severity varied widely in the first 24 hours and the prog-
ress within this early timeframe was significantly associ-
ated with mortality and ventilator-free days.
■  Improvement in oxygenation in the first 24 hours after 
the diagnosis was the most discernable predictor for 
outcomes in PARDS.
ed for inclusion in this study. All pediatric patients admitted 
to the medical ICU during this period were identified using an 
electronic database search, and two of the authors (SYK and 
BK) identified patients who fulfilled the following eligibility 
criteria: (1) acute respiratory failure requiring invasive me-
chanical ventilation, (2) at least one documented arterial blood-
gas result at the time of PARDS diagnosis, (3) diagnosis of 
PARDS according to the PALICC criteria, and (4) age older 
than 1 month. The exclusion criteria were as follows: (1) respi-
ratory failure due to cardiac failure or fluid overload, (2) con-
genital cyanotic heart disease, and (3) initiation of mechanical 
ventilation for more than 7 days before fulfilling OI ≥ 4. For 
the patients who met the inclusion criteria, clinical data were 
collected from the electronic medical records and analyzed 
retrospectively. This study was approved by the Institutional 
Review Board of the Institutional Review Board of Severance 
Hospital (IRB No. 4-2013-0207), and the informed consent re-
quirement was waived.
Data Collection and Variable Definitions
Demographics and clinical data, including PARDS etiology, 
comorbidity, Pediatric Risk of Mortality (PRISM) III score, 
clinical progress, and outcomes, were assessed. The oxygen-
ation metrics obtained were PaO2/FiO2 ratio, OI [(mean airway 
pressure × FiO2 × 100)/PaO2], and OSI [(mean airway pressure 
× FiO2 × 100)/SpO2]. All patients were classified according to 
the PALICC criteria [15] using the oxygenation metrics at the 
time of diagnosis and 24 hours afterward as follows: (1) mild 
PARDS, 4 ≤  OI < 8 or 5 ≤  OSI < 7.5, (2) moderate PARDS, 8 ≤  
OI < 16 or 7.5 ≤  OSI < 12.3, and (3) severe PARDS, OI ≥ 16 or 
OSI ≥ 12.3. Data regarding mechanical ventilation, including 
ventilator mode, peak inspiratory pressure (PIP), positive end-
expiratory pressure (PEEP), mean airway pressure, tidal vol-
ume (TV), and FiO2, were recorded at the time of PARDS diag-
nosis and 24 hours later. Driving pressure was defined as the dif-
ference between the PIP and PEEP. Changes in these variables 
over the first 24 hours (ΔPaO2/FiO2, Δdriving pressure, and ΔPIP) 
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were also determined.
 In our institution, general patient management in cases of 
progressive respiratory failure is performed using mechanical 
ventilation strategies with a minimal PEEP of 5 cmH2O, esca-
lation to 8–10 cmH2O in cases of inability to wean FiO2 below 
0.60, and attempts to maintain PIP below 30–35 cmH2O with 
TV < 5–8 mL/kg. Although there is no specific target PaO2, a 
PaO2 of at least 60 mmHg is typically accepted in cases if the 
hemodynamics and tissue oxygenation appear adequate. De-
celerating flow with either pressure-regulated volume control 
or pressure control mode of ventilation was used in the ma-
jority of cases. As both oxygenation [13,16] and driving pres-
sure [17] are associated with mortality in ARDS, pressure pa-
rameters (e.g., PIP and driving pressure) and oxygenation were 
investigated for their prognostic ability.
 The reported outcomes are ICU mortality and ventilator-free 
days (VFDs) at 28 days postdiagnosis. All instances of “venti-
lation” in this study indicate invasive ventilation; noninvasive 
support was not counted toward the ventilator days. VFDs 
were determined for survivors by subtracting the total dura-
tion of ventilation from 28 days. Patients who required ≥ 28 
ventilator days and all ICU non-survivors were designated as 
VFD = 0. This composite endpoint, which incorporates both 
mortality and length of ventilation by penalizing non-survi-
vors, is among the most commonly used surrogate endpoints 
in recent PARDS studies [18].
Statistical Analysis
The data are expressed as either percentages or medians with 
interquartile range (IQR). Categorical variables were analyzed 
using the chi-square test or Fisher exact test, and continuous 
variables were compared using the Mann-Whitney U-test. The 
main outcomes of PARDS were mortality and VFDs at day 28; 
VFDs were dichotomized into 0 days versus > 0 days and into 
≤ 14 days vs. > 14 days. Multivariate logistic regression was 
performed to test for associations between severity classifica-
tions and main outcomes, adjusting for age, sex, PRISM III 
score, comorbidity, and PARDS etiology. Initial progress dur-
ing the first 24 hours was divided into maintaining or worsen-
ing severity versus improving severity, which were evaluated 
for associations with the outcomes. Receiver operating char-
acteristic (ROC) analysis was employed to evaluate the discri-
Table 1. Demographics and baseline characteristics of the study population
Variable Total (n=288) Survived (n=176) Died (n=112) P-value
Sex (male:female) 169:119 100:76 69:43 <0.001
Age (yr) 3.7 (1.3–10.5) 2.5 (1.0–8.3) 6.0 (2.0–11.9)  0.495
PRISM III score 9.0 (5.0–14.5) 6.5 (3.0–11.0) 14.0 (9.0–20.0) <0.001
Comorbidity in ICU at admission <0.001
   Oncology 71 (45.5) 17 (20.0) 54 (76.1)
   Neurology 69 (44.2) 56 (65.9) 13 (18.3)
   Genetic syndrome 16 (10.3) 12 (14.1) 4 (5.6)
PARDS etiology <0.001
   Infectious pneumonia 182 (63.2) 130 (73.9) 52 (46.4)
   Aspiration pneumonia  33 (11.5)  23 (13.1) 10 (8.9)
   Sepsis  61 (21.2) 17 (9.7)  44 (39.3)
Initial PALICC grade <0.001
   Mild :moderate : severe 121:99:68 90:63:23 31:36:45
Progress over the first 24 hours <0.001
   Improvement in severity 151 (52.4) 118 (67.0) 33 (29.5)
Outcome
   ICU length of stay (day) 11.0 (5.0–21.0) 11.0 (7.0–21.0) 7.0 (2.0–22.0)  0.002
   Ventilator duration (day)  9.0 (5.0–20.0)  9.0 (6.0–18.0) 7.5 (3.0–23.0)  0.065
   VFDs at day 28 139 (48.3) 27 (15.3) 112 (100.0) <0.001
Values are presented as median (interquartile range) or number (%). 
PRISM: Pediatric Risk of Mortality; ICU: intensive care unit; PARDS: pediatric acute respiratory distress syndrome; PALICC: Pediatric Acute Lung Injury 
Consensus Conference; VFD: ventilator-free day.
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Figure 1. Classification of patients into Pediatric Acute Lung Injury Consensus Conference oxygenation categories based on metrics at the 
time of diagnosis (A) and 24 hours afterward (B). Both classification methods demonstrated a stepwise increase in mortality with increasing 
disease severity: mild PARDS (n=121, mortality=25.6%), moderate PARDS (n=99, 36.4%), and severe PARDS (n=68, 66.2%) according to 
metrics at diagnosis; mild PARDS (n=93, 30.1%), moderate PARDS (n=51, 41.2%), and severe PARDS (n=43, 88.4%) according to metrics at 
24 hours later. PARDS: pediatric acute respiratory distress syndrome. *Mild PARDS vs. severe PARDS: P<0.001; **Moderate PARDS vs. severe 
PARDS: P<0.001.
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minative ability of each classification at different time points 
for mortality and VFDs using the area under the curve with 
95% confidence intervals (CIs); comparisons between the two 
curves were made using DeLong’s test.
 All statistical analyses were performed with R software ver-
sion 3.2.2 (R Foundation, Vienna, Austria) and IBM SPSS ver-
sion 23.0 (IBM Corp., Armonk, NY, USA). Statistical significance 
was defined as P < 0.05.
RESULTS
Characteristics of Study Population
A total of 288 pediatric patients who met the inclusion criteria 
were included in this analysis. The characteristics of the over-
all study population and of each group, stratified according to 
survival status, are summarized in Table 1. Chronic comorbid-
ities were present in 127 patients (44.1%); the most common 
conditions were oncologic (45.5%) and neurologic (44.2%). 
Infectious pneumonia (63.2%) and sepsis (21.2%) composed 
the majority of PARDS triggers. The median length of ICU stay 
was 11 days (IQR, 5 to 21 days), the median duration of me-
chanical ventilation was 9 days (IQR, 5 to 20 days), and the 
overall mortality rate was 38.9%.
PARDS Severity Changes during the First 24 Hours
At initial diagnosis, 121 (42.0%), 99 (34.4%), and 68 (23.6%) 
patients met the criteria for the mild, moderate, and severe 
categories, respectively (Table 1). Twenty-four hours later, 25 
patients had died, and 187 out of the remaining 263 patients 
(71.1%) continued to meet the PARDS criteria; of those, 93 
cases (49.7%) were mild, 51 (27.3%) were moderate, and 43 
(23.0%) were severe. In the entire cohort, 151 patients (52.4%) 
improved in severity or recovered from PARDS, 102 (35.4%) 
maintained a stable presentation of the disease, and 35 (12.2%) 
either exhibited aggravated disease severity or died within the 
first 24 hours. There were no intergroup differences according 
to initial PARDS severity with respect to changes in severity 
(data not shown).
Association of Classification at Different Time Points with 
Outcomes in PARDS
The classifications of the patients into severity groups at the 
time of PARDS diagnosis and 24 hours afterward are depicted 
in Figure 1. Both classifications demonstrated a stepwise in-
crease in mortality with increasing disease severity: mild PARDS 
(n = 121; mortality, 25.6%), moderate PARDS (n = 99, 36.4%), 
and severe PARDS (n = 68, 66.2%) according to metrics at di-
agnosis; mild PARDS (n = 93, 30.1%), moderate PARDS (n = 51, 
41.2%), and severe PARDS (n = 43, 88.4%) according to metrics 
at 24 hours. Significant differences in mortality were noted 
with severe PARDS compared to either mild or moderate PA-
RDS (mild vs. severe PARDS, P < 0.001; moderate vs. severe 
PARDS, P < 0.001) in both classifications. Multivariate logistic 
regression analysis showed that the risk for mortality signifi-
cantly increased for the severe group under both classifications 
(adjusted odds ratio [OR], 7.16; 95% CI, 2.02 to 25.31; P = 0.002 
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for severe group at diagnosis, and adjusted OR, 26.84; 95% CI, 
3.43 to 209.89; P = 0.002 for severe group at 24 hours). Similar 
results were found for patients having no VFDs at day 28 (Ta-
ble 2). Subsequent ROC analysis demonstrated no differences 
in the discriminative ability of either mortality or VFDs between 
both classifications (Supplementary Figure 1).
Associations of Initial Progress with Outcomes
Initial progress was divided into maintaining or worsening se-
verity versus improving severity. Survivors exhibited a signifi-
cantly higher proportion of subjects with improved severity 
during the first 24 hours compared with non-survivors (67.0% 
and 29.5%, respectively; P < 0.001) (Table 1). Logistic regres-
sion analysis revealed an association between initial progress 
over the first 24 hours with PARDS outcomes after adjustment 
for potential covariates such as age, sex, PRISM III score, co-
Table 2. Multivariate regression analysis of association of classification at different time points with outcomes in PARDS
Variable
Classification at diagnosis Classification at 24 hours
Adjusted OR 95% CI P-value Adjusted OR 95% CI P-value
Mortality
   Mild (reference)
   Moderate 1.80 0.67–4.84 0.241 2.20 0.53–9.18 0.278
   Severe 7.16 2.02–25.31 0.002 26.84  3.43–209.89 0.002
VFD=0 at day 28
   Mild (reference)
   Moderate 1.73 0.73–4.11 0.213 1.58 0.41–6.16 0.507
   Severe 4.56  1.47–14.19 0.009 10.04  1.77–57.02 0.009
VFD ≤14 at day 28
   Mild (reference)
   Moderate 0.97 0.42–2.23 0.938 0.65 0.14–2.91 0.569
   Severe 8.29  1.70–40.46 0.009 6.51  0.63–67.16 0.116
ORs were adjusted for age, sex, PRISM III score, comorbidities, and PARDS etiology.
PARDS: pediatric acute respiratory distress syndrome; OR: odds ratio; CI: confidence interval; VFD: ventilator-free day; PRISM: Pediatric Risk of Mortality. 
Table 3. Multivariate regression analysis of association of initial 
progress with outcomes in PARDS
Variable Adjusted OR 95% CI P-value
Mortality   
   Improvement (reference)   
   Maintain or aggravation 4.52 1.84–11.08  0.001
VFD=0 at day 28
   Improvement (reference)
   Maintain or aggravation 4.62 2.00–10.70 <0.001
VFD ≤14 at day 28
   Improvement (reference)
   Maintain or aggravation 3.32 1.43–7.73 0.005
ORs were adjusted for age, sex, PRISM III score, comorbidities, and PARDS 
etiology.
PARDS: pediatric acute respiratory distress syndrome; OR: odds ratio; CI: 
confidence interval; VFD: ventilator-free day; PRISM: Pediatric Risk of 
Mortality.
Table 4. Discriminative ability of respiratory variables for mortali-
ty and VFD 
Variable
Area under 
the curve
95% CI P-value
Mortality   
   ΔPaO2/FiO2 0.701 0.636–0.766 <0.001
   ΔDriving pressure 0.570 0.498–0.641 <0.001
   ΔPIP 0.583 0.511–0.656 <0.001
VFD=0 at day 28
   ΔPaO2/FiO2   0.658 0.592–0.725 <0.001
   ΔDriving pressure 0.554 0.486–0.623 <0.001
   ΔPIP 0.578 0.509–0.646 <0.001
VFD ≤14 at day 28
   ΔPaO2/FiO2 0.613 0.543–0.683 <0.001
   ΔDriving pressure 0.584 0.516–0.652 <0.001
   ΔPIP 0.611 0.545–0.678 <0.001
VFD: ventilator-free day; CI: confidence interval; ΔPaO2/FiO2: changes in 
arterial partial pressure of oxygen to fraction of inspired oxygen for the 
first 24 hours; ΔDriving pressure: changes in driving pressure for the 
first 24 hours; ΔPIP: changes in peak inspiratory pressure for the first 24 
hours.
Kim SY, et al. Risk Stratification in PARDS
https://www.accjournal.org 227Acute and Critical Care 2018 November 33(4):222-229
morbidity, and PARDS etiology. Maintaining or worsening se-
verity was significantly associated with mortality (adjusted 
OR, 4.52; 95% CI, 1.84 to 11.08; P = 0.001) and VFD = 0 at day 
28 (adjusted OR, 4.62; 95% CI, 2.00 to 10.70; P<0.001) (Table 3).
Discriminative and Predictive Ability of Early Oxygenation 
Response
Based on the ROC analysis, ΔPaO2/FiO2, Δdriving pressure, 
and ΔPIP all discriminated mortality and VFD, but the AUC of 
ΔPaO2/FiO2 was consistently higher than the AUCs of the oth-
er factors (Table 4). For mortality, the AUC of ΔPaO2/FiO2 was 
statistically higher compared to that of either Δdriving pres-
sure or ΔPIP (Supplementary Figure 2), indicating superior 
predictive validity. Regression analysis confirmed that incre-
asing PaO2/FiO2 was significantly associated with incre ased 
mortality and decreased VFD (Table 5). After adjusting for 
age, sex, PRISM III score, comorbidities, PARDS etiology, and 
initial PALICC oxygenation severity, an OR of 1.09 was deter-
mined for the odds of death with each increase of 10 in PaO2/
FiO2 (P=0.002) over the first 24 hours (95% CI, 1.03 to 1.15). Sim-
ilarly, an incre ase of 10 in PaO2/FiO2 resulted in an OR of 1.05 
for VFD = 0 at day 28 (95% CI, 1.00 to 1.09; P = 0.031) (Table 5).
DISCUSSION
In this study, PARDS severity changed frequently in the first 
24 hours after diagnosis. Reclassification 24 hours after diag-
nosis provided similar effectiveness in outcome stratification 
of PARDS subjects compared with classification by using the 
initial metrics. Notably, progress within the first 24 hours was 
significantly associated with mortality and VFDs. Among a 
variety of clinical variables in this early timeframe, changes in 
oxygenation provided the most discernible predictor for out-
comes in PARDS.
 Several groups have demonstrated the discriminative ability 
of oxygenation metrics 24 hours after onset for outcomes in 
ARDS compared with those of metrics at onset [8,13,14]. Yehya 
et al. [13] reported that PaO2/FiO2 and OI, measured 24 hours 
after meeting ARDS criteria, accurately stratified the severity 
of lung injury. Parvathaneni et al. [14] reported up to 50% mor-
tality in children who were categorized with severe ARDS at 24 
hours. Although there was no difference in the discriminative 
power for mortality between PALICC criteria at diagnosis and 
24 hours afterward, our findings revealed a significant associa-
tion between initial progress within 24 hours and outcomes in 
PARDS. Subjects who showed identical or worsening severity 
within the first 24 hours exhibited an approximately three to 
four times higher risk for mortality and fewer VFDs. Moreover, 
those who were placed in the severe group at 24 hours dem-
onstrated nearly 90% mortality, which implies a benefit for re-
classification at 24 hours after PARDS diagnosis.
 Although the cross-sectional nature of this study did not allow 
for determination of causality, the significant association of early 
progress in PARDS with final outcomes has critical implications. 
A possible hypothesis for this association is that differing re-
sponses to early phase resuscitation, including lung recruitment 
and subsequent improvement in ventilation/perfusion mis-
matches, might lead to different disease progression after onset. 
Indeed, the severity of PARDS changed widely in the first 24 
hours, such that nearly two-thirds of patients were reclassified 
into categories of different severity. As there were no differences 
in these category changes in terms of the initial severity of 
PARDS, our results also highlight the importance of early inter-
ventions in the management of PARDS. Future prospective trials 
with larger cohorts are required to establish evidence-based in-
terventions regarding populations who are most likely to benefit 
from changes in treatment within the first 24 hours.
 Interestingly, we have shown that improvement in oxygen-
ation was the most discernable predictor for outcomes in PA-
RDS. Although changes in PIP, driving pressure, and PEEP 
also discriminated outcomes, ΔPaO2/FiO2 demonstrated su-
perior prognostic ability for mortality compared with the oth-
er variables. This finding is consistent with a recent report by 
Yehya and Thomas [19] that verified that PaO2/FiO2 at 24 hours 
and ΔPaO2/FiO2 were exclusively associated with mortality, 
while pressure variables, including ΔPIP, Δdriving pressure, 
and ΔPEEP, were not. This distinguishing association between 
oxygenation response and survival indicates that oxygenation 
is a more appropriate surrogate metric for outcomes in PARDS 
compared with PIP or driving pressure. This finding raises 
questions regarding the beneficial effects of existing ventila-
tion strategies in children that strictly limit TV and PIP [15,20]. 
Table 5. Multivariate regression analysis of association of initial 
oxygenation response with outcomes in PARDS
Variable Adjusted OR 95% CI P-value
Maintained or aggravated severity 1.54 1.31–1.80 <0.001 
Mortality 1.09 1.03–1.15  0.002
VFD=0 at day 28 1.05 1.00–1.09  0.031
VFD ≤14 at day 28 1.02 0.99–1.06  0.249
ORs were adjusted for age, sex, PRISM III score, comorbidities, PARDS 
etiology, and initial PALICC severity classification.
PARDS: pediatric acute respiratory distress syndrome; OR: odds ratio; CI: 
confidence interval; VFD: ventilator-free day; PRISM: Pediatric Risk of 
Mortality; PALICC: Pediatric Acute Lung Injury Consensus Conference.
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Considering that the evidence for the effectiveness of low-TV 
ventilation in children has not been consistent [21], and that 
children exhibit a different respiratory physiology [5] that might 
result in dissimilar susceptibility to ventilator-induced lung 
injury compared to adults, detailed prospective trials are need-
ed in children to identify the proper upper limits of TV, PIP, and 
driving pressure to achieve appropriate oxygenation.
 In this study, PARDS occurred in approximately 26.2% of all 
ICU admissions of children. This prevalence was much higher 
than in previous reports [7]. Moreover, the overall mortality 
rate of 38.9% was higher than the rates of previous studies per-
formed in North America [13,14,22] and Europe [8,23,24]. These 
discrepancies may result from differences in resources, socio-
economic circumstances, and patient characteristics. In our 
center, pediatric patients shared an ICU with adult patients 
until the year 2016, when the pediatric ICU was first established. 
For countries with limited resources, the indications for ICU 
admission are relatively more stringent than in more devel-
oped countries, which might lead to this increased incidence 
of PARDS in the ICU. Indeed, a recent meta-analysis demon-
strated that studies performed in Asia had higher overall mor-
tality than studies performed in Western countries [7]; the mor-
tality result in our study is within the range of reported mortal-
ity in Asia [25-27]. In addition, postsurgical, cardiac, and neo-
natal cases are treated in separate specialized units in our cen-
ter. As we have a large number of patients in the hematology-
oncology and epilepsy centers, an increased incidence of these 
comorbidities might contribute to the increased mortality. In 
this study, logistic regression analysis demonstrated that mor-
tality was significantly higher in subjects with those comorbid-
ities (data not shown). Finally, subjects included in this study 
were confined to those who underwent at least one arterial 
blood-gas study; thus, mild cases could have been excluded. 
In this context, our findings demonstrate that PARDS remains 
a common cause of death in the field of pediatric critical care.
 We acknowledge several limitations to this study. First, our 
study was conducted using a limited number of patients, since 
this was a single-center study. Second, treatment protocols 
regarding ventilator management might have varied over time. 
Third, our study results are limited to relatively short-term 
outcomes. In addition, since this study was retrospectively 
designed, we cannot exclude any possible bias regarding pa-
tient identification. Further prospective validations are need-
ed to overcome the inherent limitations of this study design.
 In conclusion, we demonstrated that the implementation 
of reclassification based on oxygenation metrics 24 hours after 
the initial diagnosis appropriately stratified outcomes in PARDS. 
Progress within the first 24 hours was significantly associated 
with mortality and ventilator free days in PARDS. Among the 
variables evaluated during this early phase, oxygenation re-
sponse was the most discernable surrogate metric for mortal-
ity. These results may provide a framework to design future 
interventional trials in PARDS and to optimize clinical practices.
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Supplementary Figure 1. Discriminative ability of Pediatric Acute Lung Injury Consensus Conference (PALICC) oxygenation categories at 
different time points for (A) mortality, (B) ventilator-free day (VFD)=0 at day 28, and (C) VFD ≤14 at day 28. (D) Receiver operating charac-
teristic (ROC) curve analysis using PALICC categories at diagnosis, and at 24 hours afterward. CI: confidence interval.
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      At 24 hours 0.724 0.655–0.792 <0.001
(B) VFD=0 at day 28
      At diagnosis 0.651 0.592–0.710 <0.001 
      At 24 hours 0.683 0.615–0.752 <0.001
(C) VFD ≤14 at day 28
      At diagnosis 0.641 0.582–0.699 <0.001 
      At 24 hours 0.620 0.548–0.693 <0.001 D
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Supplementary Figure 2. Discriminative ability of tested variables for (A) mortality, (B) initial progress, (C) ventilator-free day (VFD)=0 at 
day 28, and (D) VFD ≤14 at day 28. (E) Receiver operating characteristic curve analysis using ΔPaO2/FiO2, Δdriving pressure, and ΔPIP. 
ΔPaO2/FiO2: changes in arterial partial pressure of oxygen to fraction of inspired oxygen for the first 24 hours; ΔDriving pressure: changes 
in driving pressure for the first 24 hours; ΔPIP: changes in peak inspiratory pressure for the first 24 hours; CI: confidence interval.
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